March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Management Of Uveal Melanomas With Extraocular Extension: Enucleation Versus Plaque Radiotherapy
Author Affiliations & Notes
  • Ahmet Sarici
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Arman Mashayekhi
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Carol L. Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Swati Kaliki
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Saad AlDahmash
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Jerry A. Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  Ahmet Sarici, None; Arman Mashayekhi, None; Carol L. Shields, None; Swati Kaliki, None; Saad AlDahmash, None; Jerry A. Shields, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3407. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ahmet Sarici, Arman Mashayekhi, Carol L. Shields, Swati Kaliki, Saad AlDahmash, Jerry A. Shields; Management Of Uveal Melanomas With Extraocular Extension: Enucleation Versus Plaque Radiotherapy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3407.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare enucleation (group A) versus plaque radiotherapy (group B) for managing uveal melanoma with extraocular extension (EOE).

Methods: : Retrospective analysis of 183 patients of uveal melanoma patients with EOE.

Results: : Groups A (n=97) and B (n=86) had a mean tumor thickness of 8.7 and 6.5mm with a mean EOE thickness of 1.5 and 1.3 mm, respectively. At a mean follow-up of 28 and 45 months in the two groups, metastatic rates were 29 % and 21% respectively. Group A had orbital recurrence in 2 patients and group B had intraocular recurrence in 6 patients.

Keywords: uvea • tumors • oncology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×